Frank Stephen Hodi

23PUBLICATIONS
322CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Computational imagingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 21, 2026
Tobacco Use and Cessation Patterns Among Cancer Survivors: Results From Nine ECOG-ACRIN Cancer Research Group Trials.

|Mar 24, 2026
Same-Slide Spatial Multiomics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.

Stephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo

|Nov 20, 2025
Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.

Kimberly J Perez, Nora Horick, Joanna Baginksa

|Jul 25, 2025
First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors.

Omid Hamid, Dana B Cardin, F Stephen Hodi

|Jul 03, 2025
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047.

Evan J Lipson, Sonia Dolfi, Hao Tang

|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma.

Ahmad A Tarhini, Alyssa Obermayer, Sandra J Lee

Pageof 4

Frequent Collaborators

7 joint publications

Anita Giobbie-Hurder

6 joint publications

Scott J Rodig

4 joint publications

Michael P Manos

4 joint publications

Jason L Weirather